Ascendia Pharmaceuticals Named to Inc. 5000 List for Third Consecutive Year

Sep 8, 2022 12:00:00 AM

cGMP Manufacturing in the Pharmaceutical Industry

Sep 1, 2022 12:00:00 AM

Long-Acting Injectables (LAIs): Benefits & Drug Development

Sep 1, 2022 12:00:00 AM

Steps to Overcome Challenges Associated with Biologic Formulation Development

Aug 22, 2022 12:00:00 AM

Liposome vs. Lipid Nanoparticle: What’s the Difference?

Jul 28, 2022 12:00:00 AM

Pharmaceutical Nanotechnology: What to Know

Jul 28, 2022 12:00:00 AM

Ophthalmic Formulation Development: Inside Ophthalmic Preparation

Jul 28, 2022 12:00:00 AM

Wet Milling vs. Dry Milling in the Pharmaceutical Industry

Jul 28, 2022 12:00:00 AM

Ascendia Pharmaceuticals Included in 2022 United States Life Sciences Report

Jul 7, 2022 12:00:00 AM

Drug Formulation Development: Quick Reference Guide

Jun 27, 2022 12:00:00 AM

Ascendia Pharmaceuticals Provides Perspective on Life Science Market During CPHI North America

Jun 27, 2022 12:00:00 AM

Phase 1 Manufacturing: How to Prepare

Jun 27, 2022 12:00:00 AM